摘要
目的探讨23G经结膜无缝合玻璃体切除系统（23GTVS）在玻璃体积血中的应用，评估其疗效及安全性。方法回顾性分析通过23GTSV行玻璃体切除治疗玻璃体积血52例（62眼），术后随访3～12个月。观察最佳矫正视力、眼压及术中、术后并发症等。结果62眼中增生性糖尿病性视网膜病变（PDR）致玻璃体积血者最多，为26眼（41．94％）；其次为视网膜分支静脉阻塞（BR—VO）16眼（25．81％），再次为外伤性玻璃体积血6眼（9．68％），年龄相关性黄斑病变7眼（11．29％），其他7眼（11．29％）。所有病例均顺利完成手术，术后最佳矫正视力均有提高，与术前比较差异有统计学意义。术后眼压正常，无严重并发症发生。结论对各种原因引起的玻璃体积血，23GTVS是一种安全有效的微创手术方法。
Objective To investigate the cause of vitreous hemorrhage and the clinical effect of 23- gauge transconjunctival sutureless vitrectomy system in the treatment of vitreous hemorrhage. Methods 52 ca- ses （62 eyes） managed with 23-gauge vitrectomy were retrospectively reviewed. All surgeries were performed in our hospital from June 2010 to February 2011. The follow-up time was 3 to 12 months . The main observed i- tems included the best corrected visual acuity, intraocular pressure, intraoperative and postoperative complica- tions. Results The proliferative diabetic retinopathy （PDR） was the most common cause（26 eyes,41.94% ） for vitreous hemorrhage. The second one was branch retinal vein occlusion （BRVO, 16 eyes, 25.81% ）. The third and fourth most common causes were age related macular degeneration （ARMD ,7 eyes, 11.29% ） and traumatic vitreous hemorrhage （6 eyes, 9.68% ）. The other causes for vitreous hemorrhage accounted for 11.29%. All surgeries were successfully completed and the best corrected visual aeuities were improved in all cases. The mean postoperative intraocular pressure was normal. No intraoperative complications and serious postoperative complications were observed. Conclusion 23-gauge transconjunctival sutureless vitrectomy sys- tem is an effective and safe surgical technique in the management of vitreous hemorrhage.
出处
《中华眼外伤职业眼病杂志》
2013年第2期95-97,共3页
Chinese Journal of Ocular Trauma and Occupational Eye Disease
